Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Change in Cash: 2022-2024

Historic Change in Cash for Addex Therapeutics (ADXN) over the last 2 years, with Dec 2024 value amounting to $202.4 billion.

  • Addex Therapeutics' Change in Cash was N/A to $202.4 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 billion, marking a year-over-year change of. This contributed to the annual value of -$708,648 for FY2024, which is 76.73% up from last year.
  • As of Q4 2024, Addex Therapeutics' Change in Cash stood at $202.4 billion, which was up 39,948,601.96% from -$506,697 recorded in Q3 2024.
  • Addex Therapeutics' Change in Cash's 5-year high stood at $202.4 billion during Q4 2024, with a 5-year trough of -$196.1 billion in Q2 2024.
  • For the 2-year period, Addex Therapeutics' Change in Cash averaged around $1.1 billion, with its median value being -$6.1 million (2022).